Back to STATE STREET CORP STATE STREET CORP

NTLANTLA

Showing 8 of 28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in INTELLIA THERAPEUTICS INC

Yes. State Street holds 9,234,987 shares of NTLA (Intellia Therapeutics), worth $156.3M, as of its Q2 2026 13F filing. It increased the position by 2,312,311 shares (+33.4%) from Q1 2026. State Street has held NTLA in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$156.3M

Current Shares

9.2M

Total Value Change

+$50.6M

Total Shares Change

+4.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.2M
+33.4%
$156.3M0.0%$16.92
39
2026-Q1
Increased
6.9M
+7.8%
$88.7M0.0%$12.82
32
2025-Q4
Increased
6.4M
+29.1%
$57.7M0.0%$8.99
37
2025-Q3
Increased
5M
+23.1%
$85.8M0.0%$17.27
36
2025-Q2
Decreased
4M
-10.4%
$37.9M0.0%$9.38
0
2025-Q1
Decreased
4.5M
-13.4%
$32.1M0.0%$7.11
0
2024-Q4
Increased
5.2M
+1.2%
$60.7M0.0%$11.66
30
2024-Q3
Increased
5.1M
+17.9%
$105.7M0.0%$20.55
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used